Introduction
The demonstration by Weigand and Hotchin (1961) that lymphocytic choriomeningitis virus, which invades the central nervous system of mice, causes no disturbance in the absence of an immune response was a dramatic example of how the host's immune responses may sometimes contribute to the pathogenesis of infectious disease. The relevance of some such mechanism to the pathogenesis of experimental infections of mice with the T.P. 21 strain of Langat virus was reported by Webb et al. (1968) . Mice irradiated with 500 rads before intracerebral injection of virus had more prolonged viraemias and higher brain virus titres than controls and yet survived longer and died with little clinical or histological evidence of encephalitis. The death of the control animals from paralysis appeared to be related to the earlier production of specific antibody and cellular infiltrates, rather than to the concentration of virus in the brain. These experiments, however, did not indicate the relative importance of the cellular and humoral responses, since irradiation depresses both.
Whereas antibody levels can be measured without difficulty it is notoriously difficult to assess the cell response in mice. With some antigens, however, antilymphocyte serum will suppress both responses if given before the antigen but will not affect antibody production if given 24 hours after the antigen (Martin and Miller, 1968) . In this study we have used these effects of antilymphocyte serum to assess the relative importance of the cellular and humoral mechanisms in the pathogenesis of Langat encephalitis, and have correlated our findings with observations on the effect of Langat-sensitive lymph-node cells on virus-infected non-neuronal cells of the central nervous system in vitro.
Materials and Methods
Langat virus, both mouse-passaged (T.P. 21) and plaqueadapted (T.P. 77), were used in these experiments, and the results obtained were the same with both viruses. The viruses were obtained from Dr. C. E. Gordon Smith, of the Microbiological Research Establishment (M.R.E.), Porton. Trypsin dispersed whole brain cell suspensions from Swiss A2G mice were prepared on coverslips in Sykes Moore chambers (Illavia, 1970) and infected at the time of seeding with approximately 4-5 log doses of T.P. 21 virus; these were used five days after infection when 4-5 log doses of virus were being produced by the cells.
Antilymphocytic serum (A.L.S.) was obtained from Burroughs Wellcome & Co. (B.W.) and from the M.R.E. The A.L.S.-treated mice used in experiment 1 were injected subcutaneously within 12 hours of birth with 0-05 ml. of A.L.S. They were subsequently given 005 ml. on day 4, 0.1 ml. on days 8 and 11, 0.15 ml. on day 15, 0-2 ml. on day 10, and then 0.25 ml. twice weekly until death. They were inoculated with T.P. 21 virus at the age of 5 weeks. In experiment 2, 0.25 ml. of A.L.S. was given subcutaneously 24 hours and five days after intracerebral inoculation of virus in 5-week-old mice.
Lymph nodes were used as a source of lymphocytes and were taken from mice which had recovered from intraperitoneal injection of either T.P. Experiment 2.-The effect of A.L.S. administered 24 hours and five days after infection on the course of T.P. 21 encephalitis in 5-week-old mice was investigated. One hundred mice were given 2-3 log doses of T.P. 21 virus intracerebrally. Of these, 37 were treated with the A.L.S. (M.R.E.) and 10 with the A.L.S. (B.W.) used in experiment 1. A further 37 mice were not given A.L.S. The survival time of all mice in these three groups was recorded. The remaining mice were killed on day 8 or 9 for histological study, estimation of brain virus content, and serum haemagglutinin inhibiting antibody levels. The average survival time of the control mice (after inoculation) was 8-3 days whereas that of the A.L.S.-treated mice was 10-1 days. The figure was identical with both batches of A.L.S. Statistical analysis showed P<0.001. The titres of virus in the brains of the treated mice did not differ significantly from those of the controls (average, 6.7 log doses on day 8). All mice tested showed evidence of haemagglutinin inhibiting antibody, and the titres of treated and control mice were identical (ranging from 1/20 to 1/80). The histological changes were identical to those seen in experiment 1. It has been suggested in the past that the target-cell destruction mechanisms may play a part in the elimination of cells undergoing malignant change or of virus-infected cells (Burnet, 1968 If, therefore, suppression of target-cell destruction contributed to the prolonged survival of the A.L.S.-treated mice one must explain an apparent paradox. It is widely accepted that whereas antibodies may have an important defensive role during the viraemic phase, it is cellular immunity which combats virus infections that have become established in the tissues. A cellular immunity deficiency syndrome has been described which includes a normal incidence ef bacterial infection and normal levels of antibody to both qmses and bacteria, but abnormal susceptibility to virus infectious (Di George, 1965) . The protective role of the cell response has also been reviewed in several experimental systems (Allison, 1967) . Destruction of an infected cell is the surest way to interrupt the replication cycle of the virus. Flick and Pincus (1963) (Rogers et al., 1967 ). An excellent illustration is the case of the N.Z.B. mice, which for several years were said to suffer from a hereditary autoimmune disorder (Russel et al., 1966) . It now seems that it may be the antigen which is abnormal and not the response (Holborow and Denman, 1968) . It may be significant that virus particles have been demonstrated (East et al., 1967) .
In experiment 3, however, lymph-node cells from mice which had recovered from the infection and received booster doses of virus in Freund's complete adjuvant had a weak toxic effect on the cells even in the absence of virus. There was no infectious virus in the lymph-node suspensions from immunized mice, but it is still possible that there was enough viral antigen present to cause release of "lymphotoxin" in the chambers, as reported by Williams and Granger (1968) and Ruddle and Waksman (1968) . The absence of a cytotoxic effect when the chambers were inverted so that the lymphocytes did not contact the monolayer does not entirely eliminate this possibility, since lymphotoxin diffuses very poorly. Lymphocytes from animals immunized with Freund's complete adjuvant alone had no effect. A more likely explanation is that there was sensitization to some other antigen from the brain.
The existence of such antigens in nervous tissue, capable of giving rise to "autosensitization," is widely accepted (Waksman, 1959) , and experimental "autoallergic" encephalitis has been produced in Swiss albino mice (Olitsky and Yager, 1949 (Illavia and Webb, 1970) , and hence there may be prolonged release of potent antigen into the circulation. This release must also occur during many trivial infections of man, and so may explain why sera and lymphocytes from a small percentage of normal individuals have a cytotoxic effect on glial cells in vitro (Berg and Kallen, 1964 
Introduction
The contribution of radiology to clinical diagnosis is not in doubt, but few attempts have been made to quantitate it outside the field of gastrointestinal disease (Cooley, 1961; Rawson, 1965; Cook, 1966) . Agreement between the radiological and initial clinical diagnosis and the incidence of unexpected findings are used in this paper as indicators of the radiological diagnostic contribution. This method has obvious limitations as there is no final pathological confirmation of the diagnosis, but it has the merit of simplicity and is valid as a good approximation.
Method
All the requests for initial x-ray examinations of the chest, abdomen, skeletal structures, skull, and for intravenous pyelography, cholecystography and cholangiography, barium enemata and barium meal examinations were assessed during a six-week period. The following information was tabulated:
(1) the department of origin of the request (medical, surgical, or other specialty-including ophthalmology, E.N.T., dermatology, obstetrics and gynaecology, paediatrics-and general practitioners who have direct access to the x-ray department); (2) whether the radiological interpretation agreed with the clinical diagnosis as stated on the request card; (3) whether additional pathological lesions not anticipated by the clinician were observed-these were categorized as being (a) of interest or (b) of significance in terms of patient management; and (4) in cases where the clinician had clearly indicated that the examination was of a routine nature or that he anticipated a normal report and this was confirmed radiologically the request was designated "normal."
Of the 1,846 requests included in the study, 997 were from the medical department, 617 from the surgical department, and 232 from the other specialties, including 111 from general practitioners. Casualty requests were not included in the study.
In this survey the observer is heavily dependent on the accuracy of the clinical diagnosis on the original request card. Fortunately, a parallel study of follow-up requests (unpublished data) indicated that the original diagnosis was usually retained for subsequent examinations, supporting the view that it was likely to be correct in most cases. ' Consultant Radiologist, Southern General Hospital, Glasgow S.W. 1.
Results "Normal" Requests
Of 242 requests received, 223 were for chest x-ray examination (125 medical, 71 surgical, and 27 from other specialties). Thirteen of the remainder were "medical" and were distributed evenly among the other examinations. The proportion of "normal" to total chest x-ray examinations for each referring group was greatest in the surgical group and least in the medical group, an incidence of 52 and 22%, respectively. The other specialties had an incidence of 38%. Four of the patients who had "normal" requests were found to have a significant additional lesion (one bronchial carcinoma, one metastases from renal carcinoma, one idiopathic cardiomegaly, and one pulmonary cyst).
